Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex

References

• Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst 2004;21:433–476.
   PubMed Web of Science ®Google Scholar
• Goel H, Rai P, Rana V, Tiwary AK. Orally disintegrating systems: innovations in formulation and technology. Recent Pat Drug Deliv Formul 2008;2:258–274.
   PubMedGoogle Scholar
• Sweetman SC. (2009). Martindale: The complete drug reference. 36th edition. London: Pharmaceutical Press, 1017.
   Google Scholar
• Laitinen R, Suihko E, Toukola K, Björkqvist M, Riikonen J, Lehto VP et al. Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization. Eur J Pharm Biopharm 2009;71:271–281.
   PubMed Web of Science ®Google Scholar
• Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 2004;58:265–278.
   PubMed Web of Science ®Google Scholar
• Wang S, Ding Y, Yao Y. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Drug Dev Ind Pharm 2009;35:808–813.
   PubMed Web of Science ®Google Scholar
• Klein S, Wempe MF, Zoeller T, Buchanan NL, Lambert JL, Ramsey MG et al. Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-beta-cyclodextrin. J Pharm Pharmacol 2009;61:23–30.
   PubMed Web of Science ®Google Scholar
• Parmar KR, Patel KA, Shah SR, Sheth NR. Inclusion complexes of lamotrigine and hydroxyl propyl β-cyclodextrin: solid state characterization and dissolution studies. J Incl Phenom Macrocycl Chem 2009;65:263–268.
   Web of Science ®Google Scholar
• Ranpise NS, Kulkarni NS, Mair PD, Ranade AN. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Pharm Dev Technol 2010;15:64–70.
   PubMed Web of Science ®Google Scholar
• Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004;272:1–10.
   PubMed Web of Science ®Google Scholar
• Laitinen R, Suihko E, Bjorkqvist M, Riikonen J, Lehto VP, Jarvinen K et al. Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation. Drug Dev Ind Pharm 2010;36:601–613.
   PubMed Web of Science ®Google Scholar
• Turunen E, Mannila J, Laitinen R, Riikonen J, Lehto VP, Järvinen T et al. Fast-dissolving sublingual solid dispersion and cyclodextrin complex increase the absorption of perphenazine in rabbits. J Pharm Pharmacol 2011;63:19–25.
   PubMed Web of Science ®Google Scholar
• Cappello B, di Maio C, Iervolino M, Miro A, Calignano A. Etodolac/cyclodextrin formulations: physicochemical characterization and in vivo pharmacological studies. Drug Dev Ind Pharm 2009;35:877–886.
   PubMed Web of Science ®Google Scholar
• Veiga F, Fernandes C, Teixeira F. Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes. Int J Pharm 2000;202:165–171.
   PubMed Web of Science ®Google Scholar
• Zeng J, Ren Y, Zhou CL, Yu SQ, Chen WH. Preparation and physicochemical characteristics of the complex of edaravone with hydroxypropyl-β-cyclodextrin. Carbohyd Polym 2011;83:1101–1105.
   Web of Science ®Google Scholar
• Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum 1965;4:117–212.
   Google Scholar
• Rahman Z, Zidan AS, Khan MA. Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation. Int J Pharm 2010;400:49–58.
   PubMed Web of Science ®Google Scholar
• Abdelbary A, Elshafeey AH, Zidan G. Comparative effects of different cellulosic-based directly compressed orodispersable tablets on bioavailability of famotidine. Carbohyd Polym 2009;77:799–806.
   Web of Science ®Google Scholar
• Rajitha K, Shravan KY, Adukondalu D, Ramesh G, Madhusudan Y. Formulation and Evaluation of Orally Disintegrating Tablets of Buspirone. Int J Pharm Sci and Nanotechnol 2009;1:372–374.
   Google Scholar
• Fernandes CM, Teresa Vieira M, Veiga FJ. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Eur J Pharm Sci 2002;15:79–88.
   PubMed Web of Science ®Google Scholar
• Aki H, Niiya T, Iwase Y, Kawasaki Y, Kumai K, Kimura T. Multimodal inclusion complexes of ampicillin with β-cyclodextrins in aqueous solution. Thermochim Acta 2004;416:87–92.
   Web of Science ®Google Scholar
• Carrier RL, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release 2007;123:78–99.
   PubMed Web of Science ®Google Scholar
• Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJ. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin. Eur J Pharm Biopharm 2007;67:531–539.
   PubMed Web of Science ®Google Scholar
• Phillip Lee YH, Sathigari S, Jean Lin YJ, Ravis WR, Chadha G, Parsons DL et al. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies. Drug Dev Ind Pharm 2009;35:1113–1120.
   PubMed Web of Science ®Google Scholar
• Badr-Eldin SM, Elkheshen SA, Ghorab MM. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Eur J Pharm Biopharm 2008;70:819–827.
   PubMed Web of Science ®Google Scholar
• Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS et al. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm 2007;66:413–421.
   PubMed Web of Science ®Google Scholar
• Lutka A, Prange W. Comparison of the effect of the R2 phenothiazine ring substituent on fluphenazine and perphenazine interactions with cyclodextrins. Acta Pol Pharm 2005;62:419–425.
   PubMedGoogle Scholar
• Sheshala R, Khan N, Darwis Y. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate. Chem Pharm Bull 2011;59:920–928.
   PubMed Web of Science ®Google Scholar
• Abed KK, Hussein AA, Ghareeb MM, Abdulrasool AA. Formulation and optimization of orodispersible tablets of diazepam. AAPS PharmSciTech 2010;11:356–361.
   PubMed Web of Science ®Google Scholar
• Jeong SH, Lee J, Woo JS. (2010). Fast disintegrating tablets. In: Wen H, Park K, ed. Oral controlled release formulation design and drug delivery: theory to practice. New Jersey: John Wiley & Sons, Inc., 155–167.
   Google Scholar
• Bredenberg S, Duberg M, Lennernäs B, Lennernäs H, Pettersson A, Westerberg M et al. In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance. Eur J Pharm Sci 2003;20:327–334.
   PubMed Web of Science ®Google Scholar